Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT04206631Phase 1Completed
Phase 1, randomised, double-blind trial of doxycycline in acne vulgaris, sponsored by Universitas Indonesia. Primary endpoint: Change from Baseline Inflammatory Lesions at 6 weeks. Started Apr 2015; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT04206631.